RecruitingPhase 4NCT07271420
Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients
Sponsor
Chinese University of Hong Kong
Enrollment
40 participants
Start Date
Jan 1, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether a type of diuretic (water pill) called a thiazide can help control high blood pressure in patients who are on peritoneal dialysis — a home-based kidney replacement therapy where fluid is cycled through the abdomen. Many dialysis patients retain some kidney function that thiazides may be able to target.
**You may be eligible if...**
- You are currently on chronic peritoneal dialysis
- You have uncontrolled high blood pressure (systolic above 140 mmHg or diastolic above 90 mmHg)
**You may NOT be eligible if...**
- Your life expectancy is less than 3 months
- You are planning to switch to hemodialysis or receive a kidney transplant within 3 months
- You have a known allergy to thiazide diuretics
- You have a condition that makes thiazide use unsafe
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGHydrochlorothiazide 25mg once per day
Thiazides diuretics
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07271420
Related Trials
Genetics of Type 2 Diabetes in West Africans
NCT008371225 locations
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT061870121 location
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731152 locations
Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.
NCT037624991 location